Advertisement · 728 × 90

Posts by Matosevic Lab

Post image

Enjoyed visiting Rush University’s Department of Microbial Pathogens and Immunity in Chicago; met amazing students and spoke to faculty who do incredible work. And if you enjoy long walks, here’s a photo of a super long and wide hallway in the Cook County Hospital, now a hotel, on the Rush campus.

11 months ago 2 0 1 0
Preview
The diversity of natural killer cell functional and phenotypic states in cancer - Cancer and Metastasis Reviews The role of natural killer (NK) cells as immune effectors is well established, as is their utility as immunotherapeutic agents against various cancers. However, NK cells’ anti-cancer roles are suppres...

Excited to share our latest article where we review patient studies (and some preclinical data) to uncover the breadth of NK cell diversity (and some dysfunction) in various cancers — great work Rishabh! link.springer.com/article/10.1...

1 year ago 2 0 0 0
Post image

💪 Persistence makes progress.

Here's to 2025. 🎇

#Purdue #Cancer #Science #NewYear #HappyNewYear #HappyNYE #Happy2025 #Research #NewYearsEve #celebrate #NewYear2025 #Indiana #College

1 year ago 3 1 0 0
Post image

Incredible undergraduate student Khanh presented her first research poster at the Purdue Undergraduate Research Expo. The first of many I’m sure. It was a success! Very proud of her. #nkcells #immunotherapy

1 year ago 1 0 0 0

Would love to be added — thank you

1 year ago 1 0 0 0
Preview
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas - Nature We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M+ diffuse midline glioma (DMG), finding that intravenous administration of GD2-CART, followed by i...

Listen up 👂
It's hard to over-hype this paper from Michelle Monje and Crystal Mackall on cellular therapy for #DIPG, a fatal childhood brain cancer.

It's not a perfect therapy; doesn't always work. By goodness, what progress we are making!

#CanSky
#MEDsky
#PedCanSky

www.nature.com/articles/s41...

1 year ago 64 21 0 2
Preview
Beyond the blood: expanding CAR T cell therapy to solid tumors - Nature Biotechnology Recent clinical trials testing CAR T cells on solid tumors have yielded promising outcomes that can be enhanced with further CAR engineering.

Beyond the blood: expanding CAR T cell therapy to solid tumors. #CART #CellTherapy #NatureBiotechnology
www.nature.com/articles/s41...

1 year ago 1 1 0 0
Post image Post image

Incredible to be in the north hills of Croatia to speak about immune cell modulation and immunotherapy courtesy of the Croatian Chemical Society. Hope it’s the first of more trips back! #croatia #nkcells

1 year ago 1 0 0 0